Fetal neural tube defects: Maternal serum and amniotic fluid activin A levels [2]

Prenatal Diagnosis

Volumn 24, Issue 7, 2004, Pages 574-575

  Florio, P ^a   Lambert Messerlian, G ^b   Severi, F M ^a   Buonocore, G ^a   Canick, J A ^b   Petraglia, F ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A;

AMNION FLUID; ANENCEPHALUS; DISEASE MARKER; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; LETTER; MATERNAL SERUM; NERVOUS SYSTEM DEVELOPMENT; NEURAL TUBE DEFECT; PREGNANCY; PRIORITY JOURNAL; SPINA BIFIDA;

EID: 4043178422     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.829     Document Type: Letter

References (13)

1. Altmann CR, Brivanlou AH. 2001. Neural patterning in the vertebrate embryo. Int Rev Cytol 203: 447-482.
2. Canick JA, Knight GJ, Palomaki GE, Haddow JE. 1990. Second-trimester levels of maternal serum unconjugated oestriol and human chorionic gonadotropin in pregnancies affected by fetal anencephaly and open spina bifida. Prenat Diagn 10: 733-737.
3. Florio P, Cobellis L, Luisi S, et al. 2001. Changes in inhibins and activin secretion in healthy and pathological pregnancies. Mol Cell Endocrinol 180: 123-130.
4. Lambert-Messerlian GM, Palomaki GE, Canick JA. 2000. Second trimester levels of maternal serum inhibin A in pregnancies affected by fetal neural tube defects. Prenat Diagn 20: 680-682.
5. Luisi S, Battaglia C, Florio P, et al. 1998. Activin A and inhibin B in extra-embryonic coelomic and amniotic fluids, and maternal serum in early pregnancy. Placenta 19: 435-438.
6. Luisi S, Florio P, Reis FM, Petraglia F. 2001. Expression and secretion of activin A: possible physiological and clinical implications. Eur J Endocrinol 145: 225-236.
7. Miyakawa I, Ikeda I, Nakayama M, Maeyama M. 1976. Plasma concentrations of cortisol, progesterone and unconjugated oestradiol and oestriol in women with live anencephalic foetuses before, during and after labour. J Endocrinol 69: 291-292.
8. Muttukrishna S, Chamberlain P, Evans LW, Asselin J, Groome NP, Ledger WL. 1999. Amniotic fluid concentrations of dimeric inhibins, activin A and follistatin in pregnancy. Eur J Endocrinol 140: 420-424.
9. Petraglia F, Gomez R, Luisi S, et al. 1999. Increased midtrimester amniotic fluid activin A: a risk factor for subsequent fetal death. Am J Obstet Gynecol 180: 194-197.
10. Reis FM, D'Antona D, Petraglia F. 2002. Predictive value of hormone measurements in maternal and fetal complications of pregnancy. Endocr Rev 23: 230-257.
11. Riley SC, Balfour C, Wathen NC, et al. 1998. Follistatin and activin A in extra-embryonic coelomic and amniotic fluids and maternal serum in early pregnancy. Hum Reprod 13: 2624-2628.
12. Sagen N, Ulstein M, Romslo I, Stoa KF. 1979. Plasma estriol, progesterone, Cortisol, placental lactogen and alpha-fetoprotein in a pregnancy with an anencephalic fetus followed from the seventh week till term. Acta Obstet Gynecol Scand 58: 305-307.
13. Tuuri T, Eramaa M, Hilden K, Ritvos O. 1994. The tissue distribution of activin beta A- and beta B-subunit and follistatin messenger ribonucleic acids suggests multiple sites of action for the activin-follistatin system during human development. J Clin Endocrinol Metab 78: 1521-1524.